The Use of Hyaluronic Acid in the Treatment of Ocular Hypotonia
An ocular hypotensive syndrome may result from chronically recurring uveitis and it may lead to a considerable reduction of vision. Under certain conditions the intraocular pressure may be raised for several months in these cases by intraocular injections of Healon®. These conditions, as defined after analysis of a case observed by us, are a pathological increase in outflow resistance of the trabecular system and a reduction, though not arrest, of the production of aqueous humour (Körner et al. 1985, 1986).
KeywordsArthritis Corticosteroid Flare Resis Glaucoma
Unable to display preview. Download preview PDF.
- Hultsch E, Balazs EA (1975) Transport of hyaluronic acid from vitreous: mechanism and dynamics. Annual Meeting of the Association for Research and Ophthalmology (Arvo), p 2Google Scholar
- Moses RA (1975) Intraocular pressure. In: Moses RA (ed.) Adler’s Physiology of the Eye. Clinical Application, 6th ed. Mosby, St. Louis, pp 179-209Google Scholar
- Schubert H, Denlinger JL, Balazs EA (1981) Na-Hyaluronate injected into the anterior chamber of the owl monkey: effect on IOP and rate of disappearance. Invest Ophthalmol Vis Sci (Suppl) 20: 118Google Scholar